(Date:11/25/2009)...Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceutical...illhosttwoinvestoreventsinDecember: ,, ASHBri....ET ,, Principalinvestigatorswilldiscussdatap...refractorymultiplemyeloma,asfeaturedatthe51stAmeri...ioninNewOrleans,LA.Theteleconferencewillbeginat9:0...
(Date:11/25/2009)...ewswire/-SentinelleMedicalInc.,aleadingmanufacture...aunchesasuiteofnewleadingedgeclinicalapplicationso...ear,sRadiologicalSocietyofNorthAmerica(RSNA)annual...).Theapplicationsleveragetheuniquehighqualityimage...andsupportmultipleimagingmodalitiesformulti-parame...
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--AnarticlebyJanetWood...nandResearch,titled"ADifficultBalance-PainManageme...sueofTheNewEnglandJournalofMedicine. ,, (Logo: ...GO ) ,, Inthearticle,WoodcockdiscussesFDAeffort...hosewhoneeditandmanagingtherisksposedbyvariousanal...
(Date:11/25/2009)...5/PRNewswire/--TheBayAreaAirQualityManagementDistr...e Air Alert forThursday,November26,2009whi...lidfuel,bothindoorsandoutdoors. ,, "Cold,stillw..."saidJackBroadbent,executiveofficeroftheAirDistric...theirneighborsandfellowcommunitymembersthisThanksg...
(Date:11/25/2009)...esticular cancer who were treated with cisplatin-b...cluding neurological side effects and Raynaud-like...motherapy, according to a new study published onli...cer Institute . , Marianne Brydy, M.D., of the D...al, in Bergen, Norway, and colleagues conducted a ...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2...stantially higher rates of mental health problems ...from a systematic review and meta-analysis publish...studies over the past four decades containing data...4 homeless individuals based in the US, UK, mainla...
...ed by Johns,Hopkins University in Baltimore, Mar...est research in brain plasticity and how the compa...mprove lives. Henry Mahncke, Ph.D., and Laila,Spin... itself throughout life. This strengthening of th...
...ault are unsettling; the Department of Justice rep...ctim of attempted or actual sexual assault during ...rom two universities, including the University of ...uding leaving drinks unattended. , "These findin...
...rise software and online services veteran is expec...s of Yugma,s instant web conferencing solutions ,...ecember 2, 2008 -- Yugma , the leading web confer...fficer. , , ,Vas has more than 20 years of experie...
...oration (Nasdaq: UAHC ), which owns and provides... managed care organization in Tennessee, today,ann...share repurchase program,authorizing the Company t...n market at prevailing prices from time to time at...
... UNH ) is giving Pennsylvania children the opport...bout childhood obesity, designing programs to,addr...unities. , UnitedHealth HEROES is a service-...nds-on programs to address the issue,of childhood ...
Other Medicine News:Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2(Date:11/25/2009)..., FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire...TWR ;ASX:HIN),aleadinginnovatorandprovideroflessin...evolutionizingthetreatmentofadvancedheartfailure,t...entationatthe21stAnnualPiperJaffrayHealthCareConfe...erenceisbeingheldattheNewYorkPalaceHotel,December1...
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/-...yinvasivetreatmentsforaorticdisorders,announcedtod...eedingsin,thepatentinfringementlawsuitbroughtagain...UnitedStatesDistrictCourtinIndianapolis,Indiana. ,...twhiletheUnitedStatesPatentandTrademarkOffice(USPT...
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewsw...U.S.FoodandDrugAdministration(FDA)hasacceptedforre...Aricept®(donepezilHClextendedrelease)tabletsf...(AD).Thisnewhigherdoseformulationcontains23mgofdon...adeliverysystemthatallowsforgradualreleaseofthedru...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 1Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 2Alltech Breaks Through 3A Named Top Green Company by Inc Magazine 13825 1Alltech Breaks Through 3A Named Top Green Company by Inc Magazine 13825 2Excuse Me Your Life Is Waiting 21 3A A Bridge from Addiction to Early Recovery 56125 1Excuse Me Your Life Is Waiting 21 3A A Bridge from Addiction to Early Recovery 56125 2... June 19, 2007 /PRNewswire-FirstCall/ --,Genaera C...poster,on trodusquemine (MSI-1436), its novel anti...sociation (ADA) 67th Scientific,Sessions, June 22 ...led, "Trodusquemine is a Multiple,Pathway Inhibito...iposity, and Improves Plasma Insulin and Leptin Le...
...07 /PRNewswire-FirstCall/ -- Vical,Incorporated to...G,Inc. reported positive results following interi...omplete a Phase 3 trial of an,angiogenesis product...Based on the findings that the primary efficacy,en...ical,significance and that there were no major saf...
Other Medicine Technology:Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: